4/A//SEC Filing
BIOJECT MEDICAL TECHNOLOGIES INC 4/A
Accession 0000810084-10-000005
CIK 0000810084operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:43 PM ET
Size
8.7 KB
Accession
0000810084-10-000005
Insider Transaction Report
Form 4/AAmended
FARRELL CHRISTINE
VP of Finance
Transactions
- Exercise/Conversion
BJCT Common Stock
2009-12-31+25,000→ 254,024 total - Exercise/Conversion
Restricted Stock Unit
2009-12-31−25,000→ 119,171 totalFrom: 2009-12-31→ BJCT Common Stock (25,000 underlying)
Holdings
- 85,741(indirect: By 401(k))
BJCT Common Stock
Footnotes (6)
- [F1]This amendment is to add an additional 25,000 shares that should have been included in the Form 4 filed on January 4, 2010. Vesting pursuant to the Restricted Stock Agreement dated January 30, 2008.
- [F2]Includes 3,581 ESPP shares.
- [F3]Includes 12,054 shares received for Q4 2009 401(K)
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F5]No expiration date.
- [F6]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 44,071 Restricted Stock Unit 64,000
Documents
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeoperating
IncorporatedOR
Related Parties
1- filerCIK 0000810084
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 7:43 PM ET
- Size
- 8.7 KB